Founders Grove Wealth Partners, LLC Astrazeneca PLC Transaction History
Founders Grove Wealth Partners, LLC
- $445 Billion
- Q4 2025
A detailed history of Founders Grove Wealth Partners, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Founders Grove Wealth Partners, LLC holds 2,714 shares of AZN stock, worth $242,631. This represents 0.06% of its overall portfolio holdings.
Number of Shares
2,714Holding current value
$242,631% of portfolio
0.06%Shares
1 transactions
Others Institutions Holding AZN
# of Institutions
1,545Shares Held
502MCall Options Held
5.59MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...